Full Committee Hearing
Hearing to Discuss the FDA's Review Process for products to treat rare diseases and neglected tropical diseases.
Agenda
Agenda: Food and Drug Administration's Review Process for Products to Treat Rare Diseases and Neglected Tropical Diseases.
Related Files
| Testimony of Mr. Thomas Bollyky, Visiting Fellow, Center for Global Development |
| Testimony of Dr. Jesse Goodman, Chief Scientist and Deputy Commissioner for Science and Public Health, Food and Drug Administra |
| Testimony of Dr. Christopher P. Austin, Director of the Chemical Genomics Center and Senior Advisor to the Director for Transla |
| Testimony of Ms. Gloria Steele, Senior Deputy Assistant Administrator for Global Health, USAID |
| Testimony of Dr. Emil Kakkis, President and Founder, Kakkis EveryLife Foundation |
| Testimony of Ms. Diane Edquist Dorman, Vice President for Public Policy, National Organization for Rare Disorders |
